Volume 6, Issue 3

Search all Drugs - Real World Outcomes articles

September 2019

6 articles in this issue

Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study
Hui-Min Diana Lin
Chao-Lun Lai
Samy Suissa
Original Research Article Open access 25 June 2019 Pages: 93 - 104
Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services
Ivanka Hendrix
Amy T. Page
Janet K. Sluggett
Original Research Article Open access 01 July 2019 Pages: 105 - 113
PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice
Klaus G. Parhofer
Berndt von Stritzky
W. Dieter Paar
Original Research Article Open access 06 July 2019 Pages: 115 - 123
From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work
Jean-Pierre Boissel
Frédéric Cogny
François-Henri Boissel
Original Research Article Open access 29 July 2019 Pages: 125 - 132
Part of 1 collection:

Study Design, Methodology and Data Sources for Real-World Evidence (RWE) Generation
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication
Javier Cid Ruzafa
Sinna Pilgaard Ulrichsen
Vera Ehrenstein
Short Communication Open access 02 August 2019 Pages: 133 - 140
Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
Matthew S. Duprey
Nada S. Al-Qadheeb
John W. Devlin
Short Communication Open access 09 August 2019 Pages: 141 - 149

Volume 6, Issue 3

Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study

Patterns of High-Dose and Long-Term Proton Pump Inhibitor Use: A Cross-Sectional Study in Six South Australian Residential Aged Care Services

PEARL: A Non-interventional Study of Real-World Alirocumab Use in German Clinical Practice

From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work

Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System

Journal navigation